ALKEM.NS Alkem Laboratories Ltd.
Price history
Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.
Technical indicators
ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.
MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.
Delivery volume
| Date | Traded Qty | Delivery Qty | Delivery % |
|---|---|---|---|
| 2026-08-28 | 231100 | 154134 | 66.70% |
| 2026-08-27 | 166838 | 123018 | 73.74% |
| 2026-08-26 | 44001 | 21155 | 48.08% |
| 2026-08-25 | 48065 | 26325 | 54.77% |
| 2026-08-24 | 46339 | 26045 | 56.21% |
| 2026-08-21 | 76854 | 42574 | 55.40% |
| 2026-08-20 | 85369 | 64857 | 75.97% |
| 2026-08-19 | 213076 | 140641 | 66.01% |
| 2026-08-18 | 127028 | 35682 | 28.09% |
| 2026-08-17 | 153275 | 54620 | 35.64% |
| 2026-08-14 | 635598 | 201122 | 31.64% |
| 2026-08-13 | 33025 | 15244 | 46.16% |
| 2026-08-12 | 110443 | 65679 | 59.47% |
| 2026-08-11 | 115598 | 55745 | 48.22% |
| 2026-08-10 | 82544 | 43651 | 52.88% |
| 2026-08-07 | 76165 | 24114 | 31.66% |
| 2026-08-06 | 109477 | 68284 | 62.37% |
| 2026-08-05 | 88646 | 45766 | 51.63% |
| 2026-08-04 | 37653 | 20478 | 54.39% |
| 2026-08-03 | 122664 | 75373 | 61.45% |
Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers ALKEM.NS to fetch more history.
Insider trading activity
| Disclosed | Person | Category | Type | Mode | Quantity | Value (₹) | Resulting stake | |
|---|---|---|---|---|---|---|---|---|
| 29 Mar 2022 | Deepak Kumar Singh | Employees/Designated Employees | Sell | Market Sale | 25000 | 90235579 | 2.41% | XBRL |
| 08 Mar 2022 | Mritunjay Kumar Singh | Director | Buy | Market Purchase | 3357 | 10691874 | 6.38% | XBRL |
| 08 Mar 2022 | Mritunjay Kumar Singh | Director | Buy | Market Purchase | 1643 | 5188662 | 6.38% | XBRL |
| 25 Feb 2022 | Dhananjay and Madhurima Singh Trust | Promoters | Buy | Market Purchase | 1050 | 3438750 | 0.00% | XBRL |
| 23 Feb 2022 | Dhananjay and Madhurima Singh Trust | Promoters | Buy | Market Purchase | 2000 | 6591741 | 0.00% | XBRL |
| 30 Dec 2021 | Deepak Kumar Singh | Employees/Designated Employees | Sell | Market Sale | 2000 | 6982333 | 2.43% | XBRL |
| 27 Dec 2021 | Deepak Kumar Singh | Employees/Designated Employees | Sell | Market Sale | 2000 | 6874627 | 2.43% | XBRL |
| 23 Dec 2021 | Deepak Kumar Singh | Employees/Designated Employees | Sell | Market Sale | 5000 | 17179131 | 2.44% | XBRL |
| 02 Dec 2021 | Jayanti Sinha | Promoter Group | Sell | Gift | 2000000 | 0 | 4.30% | XBRL |
| 18 Nov 2021 | Deepak Kumar Singh | Employees/Designated Employees | Sell | Market Sale | 5000 | 17862762 | 2.44% | XBRL |
| 05 Oct 2021 | Satish Kumar Singh | Promoters | Buy | Off Market | 50267 | 0 | 0.06% | XBRL |
| 05 Oct 2021 | Balmiki Prasad Singh | Director | Buy | Off Market | 50266 | 0 | 0.10% | XBRL |
| 29 Sep 2021 | Deepak Kumar Singh | Employees/Designated Employees | Sell | Market Sale | 4000 | 15696056 | 2.44% | XBRL |
| 24 Sep 2021 | Deepak Kumar Singh | Employees/Designated Employees | Sell | Market Sale | 4000 | 15672126 | 2.45% | XBRL |
| 21 Sep 2021 | Deepak Kumar Singh | Employees/Designated Employees | Sell | Market Sale | 4789 | 18505344 | 2.45% | XBRL |
| 15 Sep 2021 | Alok Kumar | Employees/Designated Employees | Buy | Off Market | 1355769 | 0 | 2.31% | XBRL |
| 14 Sep 2021 | Mr. Ashok kumar | Employees/Designated Employees | Buy | Off Market | 1355769 | 0 | 2.31% | XBRL |
| 25 Jun 2021 | Balmiki Prasad Singh | Director | Buy | Off Market | 250 | 0 | 0.06% | XBRL |
| 25 Jun 2021 | Satish Kumar Singh | Promoters | Buy | Off Market | 250 | 0 | 0.02% | XBRL |
| 22 Jun 2021 | Dhananjay Kumar Singh | Promoters | Buy | Gift | 2052305 | 0 | 7.96% | XBRL |
SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers ALKEM.NS to fetch more.
Extract this company (financials + ratios + citations): CSV · XLSX
Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score
Ratios
This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.
Growth & earnings trend
Revenue & Profit CAGR
Operating Margin Trend
ROCE Trajectory
Earnings Quality
⚠ Persistent profit/cash gap
Net Profit CAGR 32.73% vs CFO CAGR 5.27% over 3.0y (2023-03-31 → 2026-03-31); most recent year: Net Profit +6.30% vs CFO +2.62%
Sector-Relative Percentile (Healthcare)
Quarterly trend
| Metric (to shareholders basis) | Q4 FY2023-24 | Q1 FY2024-25 | Q2 FY2024-25 | Q3 FY2024-25 | Q4 FY2024-25 | Q1 FY2025-26 | Q2 FY2025-26 | Q3 FY2025-26 | Q4 FY2025-26 | Q1 FY2026-27 | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹29.36 Bn | ₹30.32 Bn | ₹34.15 Bn | ₹33.74 Bn | ₹31.44 Bn | ₹33.71 Bn | ₹40.01 Bn | ₹37.37 Bn | ₹36.03 Bn | ₹37.40 Bn | RevenueFromOperations |
| Net Profit | ₹2.94 Bn incl. minority ₹3.04 Bn | ₹5.45 Bn incl. minority ₹5.50 Bn | ₹6.89 Bn incl. minority ₹7.02 Bn | ₹6.26 Bn incl. minority ₹6.41 Bn | ₹3.06 Bn incl. minority ₹3.22 Bn | ₹6.64 Bn incl. minority ₹6.68 Bn | ₹7.65 Bn incl. minority ₹7.79 Bn | ₹6.36 Bn incl. minority ₹6.53 Bn | ₹2.36 Bn incl. minority ₹2.51 Bn | ₹5.20 Bn incl. minority ₹5.21 Bn | ProfitOrLossAttributableToOwnersOfParent |
Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers ALKEM.NS to fetch more.
Source document — income statement (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| ProfitOrLossAttributableToOwnersOfParent | 23018011000.0 |
| PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital | 119550000.0 |
Source document — balance sheet (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| CurrentAssets | 122105200000.0 |
| CurrentLiabilities | 47827000000.0 |
| EquityAttributableToOwnersOfParent | 138201000000.0 |
| BorrowingsCurrent + BorrowingsNoncurrent | 16235000000.0 |